Repinatrabit

N/A

Report date: 2026/05/08 20:02:52
NME

Base Information

Drug NameRepinatrabit
Drug Alias NameJNT-517
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium-dependent neutral amino acid transporter B(0)AT1 inhibitors
TargetsSodium-dependent neutral amino acid transporter B(0)AT1
Therapy Area/IndicationsPhenylketonurias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[10] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesJnana Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOtsuka Pharmaceutical Development & Commercialization Inc
Inactive CompaniesN/A
Active IndicationsPhenylketonurias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A